BSE Live
Jan 27, 10:40Prev. Close
442.50
Open Price
442.60
Bid Price (Qty.)
444.75 (4)
Offer Price (Qty.)
445.45 (23)
NSE Live
Jan 27, 10:40Prev. Close
440.25
Open Price
445.75
Bid Price (Qty.)
445.05 (69)
Offer Price (Qty.)
445.40 (21)
| Cash Flow of Thyrocare Technologies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 156.33 | 146.86 | 147.96 | 86.74 | 88.76 | |
| Net CashFlow From Operating Activities | 136.33 | 96.50 | 111.52 | 89.28 | 66.87 | |
| Net Cash Used In Investing Activities | 26.84 | -3.24 | -48.26 | -39.67 | -18.61 | |
| Net Cash Used From Financing Activities | -162.65 | -96.14 | -64.73 | -48.50 | -44.96 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.52 | -2.88 | -1.47 | 1.11 | 3.31 | |
| Cash And Cash Equivalents Begin of Year | 4.36 | 7.24 | 8.71 | 7.60 | 4.29 | |
| Cash And Cash Equivalents End Of Year | 4.88 | 4.36 | 7.24 | 8.71 | 7.60 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss